nasdaq:mack
|
https://www.glassdoor.com?employer_id=266798
|
266798
|
Apr 28th, 2024 12:00AM
|
Open
|
Merrimack Pharmaceuticals
|
Open
|
Company - Public
|
Biotech & Pharmaceuticals
|
|
|
Cambridge, MA
|
2002
|
3.30
|
75%
|
31%
|
46%
|
3.70
|
3.70
|
3.20
|
4.50
|
4.00
|
3.00
|
|
|
|
|
1.00
|
1.00
|
3.00
|
3.00
|
|
|
|
|
100%
|
0.00
|
0.00
|
48.00
|
0.50
|
0.40
|
0.10
|
0.50
|
|
0.30
|
0.10
|
0.10
|
|
|
|
Richard Peters, MD, PhD
|
Apr 28th, 2024 04:18PM
|
Apr 28th, 2024 04:18PM
|
Merrimack Pharmaceuticals
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
|
nasdaq:mack
|
https://www.glassdoor.com?employer_id=266798
|
266798
|
Apr 26th, 2024 12:00AM
|
Open
|
Merrimack Pharmaceuticals
|
Open
|
Company - Public
|
Biotech & Pharmaceuticals
|
|
|
Cambridge, MA
|
2002
|
3.30
|
75%
|
31%
|
46%
|
3.70
|
3.70
|
3.20
|
4.50
|
4.00
|
3.00
|
|
|
|
|
1.00
|
1.00
|
3.00
|
3.00
|
|
|
|
|
100%
|
0.00
|
0.00
|
48.00
|
0.50
|
0.40
|
0.10
|
0.50
|
|
0.30
|
0.10
|
0.10
|
|
|
|
Richard Peters, MD, PhD
|
Apr 26th, 2024 08:04AM
|
Apr 26th, 2024 08:04AM
|
Merrimack Pharmaceuticals
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
|
nasdaq:mack
|
https://www.glassdoor.com?employer_id=266798
|
266798
|
Apr 25th, 2024 12:00AM
|
Open
|
Merrimack Pharmaceuticals
|
Open
|
Company - Public
|
Biotech & Pharmaceuticals
|
|
|
Cambridge, MA
|
2002
|
3.30
|
75%
|
31%
|
46%
|
3.70
|
3.70
|
3.20
|
4.50
|
4.00
|
3.00
|
|
|
|
|
1.00
|
1.00
|
3.00
|
3.00
|
|
|
|
|
100%
|
0.00
|
0.00
|
48.00
|
0.50
|
0.40
|
0.10
|
0.50
|
|
0.30
|
0.10
|
0.10
|
|
|
|
Richard Peters, MD, PhD
|
Apr 25th, 2024 06:25PM
|
Apr 25th, 2024 06:25PM
|
Merrimack Pharmaceuticals
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
|
nasdaq:mack
|
https://www.glassdoor.com?employer_id=266798
|
266798
|
Apr 24th, 2024 12:00AM
|
Open
|
Merrimack Pharmaceuticals
|
Open
|
Company - Public
|
Biotech & Pharmaceuticals
|
|
|
Cambridge, MA
|
2002
|
3.30
|
75%
|
31%
|
46%
|
3.70
|
3.70
|
3.20
|
4.50
|
4.00
|
3.00
|
|
|
|
|
1.00
|
1.00
|
3.00
|
3.00
|
|
|
|
|
100%
|
0.00
|
0.00
|
48.00
|
0.50
|
0.40
|
0.10
|
0.50
|
|
0.30
|
0.10
|
0.10
|
|
|
|
Richard Peters, MD, PhD
|
Apr 24th, 2024 10:49AM
|
Apr 24th, 2024 10:49AM
|
Merrimack Pharmaceuticals
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
|
nasdaq:mack
|
https://www.glassdoor.com?employer_id=266798
|
266798
|
Apr 23rd, 2024 12:00AM
|
Open
|
Merrimack Pharmaceuticals
|
Open
|
Company - Public
|
Biotech & Pharmaceuticals
|
|
|
Cambridge, MA
|
2002
|
3.30
|
75%
|
31%
|
46%
|
3.70
|
3.70
|
3.20
|
4.50
|
4.00
|
3.00
|
|
|
|
|
1.00
|
1.00
|
3.00
|
3.00
|
|
|
|
|
100%
|
0.00
|
0.00
|
48.00
|
0.50
|
0.40
|
0.10
|
0.50
|
|
0.30
|
0.10
|
0.10
|
|
|
|
Richard Peters, MD, PhD
|
Apr 23rd, 2024 04:23PM
|
Apr 23rd, 2024 04:23PM
|
Merrimack Pharmaceuticals
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
|
nasdaq:mack
|
https://www.glassdoor.com?employer_id=266798
|
266798
|
Apr 21st, 2024 12:00AM
|
Open
|
Merrimack Pharmaceuticals
|
Open
|
Company - Public
|
Biotech & Pharmaceuticals
|
|
|
Cambridge, MA
|
2002
|
3.30
|
75%
|
31%
|
46%
|
3.70
|
3.70
|
3.20
|
4.50
|
4.00
|
3.00
|
|
|
|
|
1.00
|
1.00
|
3.00
|
3.00
|
|
|
|
|
100%
|
0.00
|
0.00
|
48.00
|
0.50
|
0.40
|
0.10
|
0.50
|
|
0.30
|
0.10
|
0.10
|
|
|
|
Richard Peters, MD, PhD
|
Apr 21st, 2024 04:24PM
|
Apr 21st, 2024 04:24PM
|
Merrimack Pharmaceuticals
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
|
nasdaq:mack
|
https://www.glassdoor.com?employer_id=266798
|
266798
|
Apr 20th, 2024 12:00AM
|
Open
|
Merrimack Pharmaceuticals
|
Open
|
Company - Public
|
Biotech & Pharmaceuticals
|
|
|
Cambridge, MA
|
2002
|
3.30
|
75%
|
31%
|
46%
|
3.70
|
3.70
|
3.20
|
4.50
|
4.00
|
3.00
|
|
|
|
|
1.00
|
1.00
|
3.00
|
3.00
|
|
|
|
|
100%
|
0.00
|
0.00
|
48.00
|
0.50
|
0.40
|
0.10
|
0.50
|
|
0.30
|
0.10
|
0.10
|
|
|
|
Richard Peters, MD, PhD
|
Apr 20th, 2024 04:40PM
|
Apr 20th, 2024 04:40PM
|
Merrimack Pharmaceuticals
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
|
nasdaq:mack
|
https://www.glassdoor.com?employer_id=266798
|
266798
|
Apr 19th, 2024 12:00AM
|
Open
|
Merrimack Pharmaceuticals
|
Open
|
Company - Public
|
Biotech & Pharmaceuticals
|
|
|
Cambridge, MA
|
2002
|
3.30
|
75%
|
31%
|
46%
|
3.70
|
3.70
|
3.20
|
4.50
|
4.00
|
3.00
|
|
|
|
|
1.00
|
1.00
|
3.00
|
3.00
|
|
|
|
|
100%
|
0.00
|
0.00
|
48.00
|
0.50
|
0.40
|
0.10
|
0.50
|
|
0.30
|
0.10
|
0.10
|
|
|
|
Richard Peters, MD, PhD
|
Apr 19th, 2024 07:37AM
|
Apr 19th, 2024 07:37AM
|
Merrimack Pharmaceuticals
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
|
nasdaq:mack
|
https://www.glassdoor.com?employer_id=266798
|
266798
|
Apr 18th, 2024 12:00AM
|
Open
|
Merrimack Pharmaceuticals
|
Open
|
Company - Public
|
Biotech & Pharmaceuticals
|
|
|
Cambridge, MA
|
2002
|
3.30
|
75%
|
31%
|
46%
|
3.70
|
3.70
|
3.20
|
4.50
|
4.00
|
3.00
|
|
|
|
|
1.00
|
1.00
|
3.00
|
3.00
|
|
|
|
|
100%
|
0.00
|
0.00
|
48.00
|
0.50
|
0.40
|
0.10
|
0.50
|
|
0.30
|
0.10
|
0.10
|
|
|
|
Richard Peters, MD, PhD
|
Apr 18th, 2024 05:59PM
|
Apr 18th, 2024 05:59PM
|
Merrimack Pharmaceuticals
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
|
nasdaq:mack
|
https://www.glassdoor.com?employer_id=266798
|
266798
|
Apr 17th, 2024 12:00AM
|
Open
|
Merrimack Pharmaceuticals
|
Open
|
Company - Public
|
Biotech & Pharmaceuticals
|
|
|
Cambridge, MA
|
2002
|
3.30
|
75%
|
31%
|
46%
|
3.70
|
3.70
|
3.20
|
4.50
|
4.00
|
3.00
|
|
|
|
|
1.00
|
1.00
|
3.00
|
3.00
|
|
|
|
|
100%
|
0.00
|
0.00
|
48.00
|
0.50
|
0.40
|
0.10
|
0.50
|
|
0.30
|
0.10
|
0.10
|
|
|
|
Richard Peters, MD, PhD
|
Apr 17th, 2024 02:26PM
|
Apr 17th, 2024 02:26PM
|
Merrimack Pharmaceuticals
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
|